发明名称 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
摘要 A drug delivery system (DDS) for administration of a water soluble, cationic, and amphiphilic pharmaceutically active substance (API) which DDS comprises poorly water soluble nanoparticles formed by the API together with a Na-salt of N-all-trans-retinoyl cysteic acid methyl ester and/or a Na-salt of N-13-cis-retinoyl cysteic acid methyl ester. A pharmaceutical composition comprising such a DDS. Methods for preparation of such a DDS and such a pharmaceutical composition. Use of such a DDS and pharmaceutical composition for treatment of cancer.
申请公布号 US8765173(B2) 申请公布日期 2014.07.01
申请号 US200812809259 申请日期 2008.12.18
申请人 Ardenia Investments, Ltd. 发明人 Aleksov Julian;Lokot Igor
分类号 A61K9/48 主分类号 A61K9/48
代理机构 Renner, Otto, Boisselle & Sklar, LLP 代理人 Renner, Otto, Boisselle & Sklar, LLP
主权项 1. A drug delivery system for administration of a pharmaceutically active substance that is a cationic amphiphile by itself and has a solubility per se in water of at least 4 mg/ml, wherein the drug delivery system comprises nanoparticles smaller than about 50 nm having a solubility in water below 0.1 mg/ml, said nanoparticles being formed by said substance in association with a sodium salt of the methyl ester of N-all-trans-retinoyl cysteic acid, a sodium salt of methyl ester of N-13-cis-retinoyl cysteic acid, or a combination thereof.
地址 London, Greater London GB